Trial Profile
The role of HER [human epidermal growth factor receptor] receptor family as indicator of prognosis and drug responsiveness in locally advanced prostate cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Bicalutamide (Primary) ; Gefitinib (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 19 Oct 2007 New trial record.